Nalini Murdter

Nalini Murdter has over 25 years experience in the biotech industry. Her career spans early stage as well as large established global businesses across life sciences and diagnostics markets. Most recently, Nalini held the position of President and C.E.O. of MBL International, a JSR Life Sciences company. Prior to that, she was the Chief Business Officer at NanoString Technologies, Inc.

Nalini has held senior global management positions at Agilent Technologies in Marketing, Acquisitions, Alliances and Venture Investments and Business Development. Prior to Agilent, Nalini was the Director of Product and Business Development at Adeza Biomedical Corp., a women’s healthcare company, which is now a part of Hologic, Inc. She has served on non-profit and advisory boards of start-up companies.

Nalini was a Senior Research Fellow in the Division of Biology at California Institute of Technology in Pasadena, California. She has a Ph.D. in Biochemistry from the University of Maryland, College Park and an M.B.A. from the Haas School of Business at University of California, Berkeley, California.